FRANKLIN LAKES, N.J., Feb. 12, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next ...
FRANKLIN LAKES, N.J., Sept. 2, 2025 /PRNewswire/ -- In recognition of Peripheral Artery Disease (PAD) Awareness Month, BD (Becton, Dickinson and Company) (NYSE: BDX) is shining a spotlight on a ...
Becton, Dickinson and Company (BD) today announced it has enrolled its first patient in the Agility study to assess the safety and effectiveness of the BD Vascular Covered Stent for treatment of ...
First Patient Enrollment in AGILITY Study Begins Investigations of Safety and Effectiveness of BD Vascular Covered Stent for Treatment of PAD FRANKLIN LAKES, N.J., March 4, 2024 /PRNewswire/ -- BD ...
PHOENIX — A technology campus in Tempe has its first tenant — even though it is not expected to open for two more years. BD Peripheral Intervention — which develops and manufactures endovascular ...
"The CE Marking of the Revello™ Stent is a significant advancement towards helping physicians treating complex iliac artery disease," said Rima Alameddine, worldwide president, BD Interventional – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results